A Study of Ruxolitinib Phosphate Cream When Applied to Patients With Plaque Psoriasis

NCT00820950 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Ruxolitinib phosphate cream
DRUG: Dovonex® calcipotriene 0.005%
DRUG: Diprolene® AF betamethasone dipropionate 0.05% cream.
DRUG: Placebo cream
DRUG: Ruxolitinib phosphate cream
DRUG: Ruxolitinib phosphate cream

Sponsor

Incyte Corporation